Upcoming Webinars

Advancing CNS Drug Development: Integrated Strategies Across Discovery, DMPK, and Non-Clinical Safety

September 16, 2026

CNS drug development continues to present some of the most complex challenges in biopharmaceutical research—from target validation and brain exposure to translational predictability and safety assessment. Join us on September 16 for our upcoming webinar, when experts across CNS discovery, translational pharmacology, DMPK, and non-clinical safety will explore how integrated preclinical strategies can inform candidate selection and development decisions.

Register Now

Advancing Metabolic Disease Drug Development: Integrated Preclinical Strategies from Discovery to IND-Enabling Studies

September 29, 2026

Metabolic drug development is evolving rapidly with advances in incretin biology and an increasingly complex therapeutic landscape. Moving promising candidates toward the clinic requires more than efficacy alone—it demands integrated assessment of translational relevance, tolerability, target exposure, and safety. Join us on September 29, when experts in metabolic disease, DMPK, and non-clinical safety explore integrated preclinical strategies from discovery to IND.

Register Now